Verition Fund Management’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-97,888
| Closed | -$287K | – | 2761 |
|
2024
Q2 | $287K | Sell |
97,888
-185,733
| -65% | -$544K | ﹤0.01% | 1750 |
|
2024
Q1 | $1.6M | Sell |
283,621
-339,252
| -54% | -$1.92M | 0.01% | 950 |
|
2023
Q4 | $2.67M | Sell |
622,873
-1,878,803
| -75% | -$8.06M | 0.02% | 595 |
|
2023
Q3 | $8.68M | Buy |
2,501,676
+555,016
| +29% | +$1.93M | 0.1% | 236 |
|
2023
Q2 | $9.05M | Buy |
1,946,660
+800,874
| +70% | +$3.72M | 0.12% | 201 |
|
2023
Q1 | $5.29M | Sell |
1,145,786
-458,443
| -29% | -$2.12M | 0.07% | 313 |
|
2022
Q4 | $13M | Buy |
1,604,229
+350,124
| +28% | +$2.83M | 0.2% | 90 |
|
2022
Q3 | $6.96M | Buy |
1,254,105
+529,024
| +73% | +$2.94M | 0.08% | 259 |
|
2022
Q2 | $3.78M | Buy |
+725,081
| New | +$3.78M | 0.07% | 347 |
|
2022
Q1 | – | Sell |
-184,765
| Closed | -$2.75M | – | 2227 |
|
2021
Q4 | $2.75M | Buy |
184,765
+21,758
| +13% | +$324K | 0.02% | 468 |
|
2021
Q3 | $3.08M | Buy |
163,007
+58,687
| +56% | +$1.11M | 0.03% | 310 |
|
2021
Q2 | $1.94M | Sell |
104,320
-367,012
| -78% | -$6.82M | 0.02% | 453 |
|
2021
Q1 | $10.7M | Buy |
471,332
+145,567
| +45% | +$3.31M | 0.12% | 73 |
|
2020
Q4 | $7.07M | Buy |
325,765
+120,067
| +58% | +$2.61M | 0.06% | 104 |
|
2020
Q3 | $2.07M | Buy |
+205,698
| New | +$2.07M | 0.04% | 195 |
|